Echo Therapeutics Inc $2.03

up +0.02


24/7/2014 02:35 PM  |  NASDAQ : ECTE  
Industries : Drugs / Drug Manufacturers - Major
Get Trend Analysis Icon Get ECTE Trend Analysis - it has underperformed the S&P 500 by 49%

Partner Headlines

  1. Echo Therapeutics Mails Letter to Shareholders; Urges Not to Vote Platinum's ...

    Benzinga
  2. Echo Therapeutics Comments on Proxy Contest by Platinum Management (NY) ...

    Benzinga
  3. Platinum Management (NY) LLC Urges Stockholders to Take No Action Regarding ...

    Benzinga
  4. Echo Therapeutics Submits CE Mark Technical File to European Notified ...

    Benzinga
  5. Morning Market Losers

    Benzinga
  6. Morning Market Movers

    Benzinga
  7. Echo Therapeutics Schedules Meeting with Platinum-Montaur Next Week, Still ...

    Benzinga
  8. Echo Therapeutics Announces CEO, President and Chairman, Dr. Patrick Mooney ...

    Benzinga
  9. LifeTech Capital Reiterates Neutral Rating on Echo Therapeutics Following ...

    Benzinga
  10. Echo Therapeutics Prices 13.33M Share Offering @ $0.75/Share

    Benzinga
  11. Echo Therapeutics to Report Trial Results of Symphony tCGM System at Critical ...

    Benzinga
  12. Echo Therapeutics Prices 3.2M Share Offering @$0.95/Share

    Benzinga
  13. Stocks Hitting 52-Week Lows

    Benzinga
  14. Stocks Hitting 52-Week Lows

    Benzinga
  15. Echo Therapeutics Announces Proposed Public Offering

    Benzinga
  16. Echo Therapeutics Announces $20 Million Financing with Platinum-Montaur ...

    Benzinga
  17. Benzinga's Top Initiations

    Benzinga
  18. Echo Therapeutics Announces Positive Clinical Trial Results of Symphony® ...

    Benzinga
  19. UPDATE: Wunderlich Securities Initiates Coverage of Echo Therapeutics with ...

    Benzinga
  20. Echo Therapeutics Expands License Agreement with Ferndale Pharma

    Benzinga
  21. Echo Therapeutics Presents Positive Clinical Trial Results of the Symphony ...

    Benzinga
  22. Benzinga's Top Downgrades With Color for May 14, 2012

    Benzinga
  23. Echo Therapeutics Announces Positive Clinical Trial Results of Symphony® ...

    Benzinga
  24. Echo Therapeutics Initiates Clinical Trials of its Symphony tCGM System ...

    Benzinga
  25. LifeTech Has Strong Speculative Buy, $6 PT On Echo Therapeutics

    Benzinga
Trading Center